journal article Open Access Dec 02, 2020

Waist Circumference as a Preventive Tool of Atherogenic Dyslipidemia and Obesity-Associated Cardiovascular Risk in Young Adults Males: A Cross-Sectional Pilot Study

Diagnostics Vol. 10 No. 12 pp. 1033 · MDPI AG
View at Publisher Save 10.3390/diagnostics10121033
Abstract
Although the correlation coefficient between body mass index (BMI) and poor lipid profile has been reported, representing a cardiovascular risk, the need to find new early detection markers is real. Waist circumference and markers of atherogenic dyslipidemia are not usually measured in medical review appointments. The present study aimed to investigate the relationship between central adiposity and cardiovascular risk. This was a cross-sectional pilot study of 57 young males (age: 35.9 ± 10.85, BMI: 32.4 ± 6.08) recruited from community settings and allocated to non-obese or obese attending to their waist circumference. Total cholesterol (TC), high-density lipoproteins (HDL-C), and low-density lipoproteins (LDL-C) cholesterol and triglycerides (TG) were measured from plasma samples. Patients with at least 100 cm of waist circumference had significantly increased TC, LDL-C, non-HDL-C, and triglycerides and lower levels of HDL-C. The three atherogenic ratios TC/HDL-C, LDL-C/HDL-C, and TG/HDL-C were all optimal in non-obese patients. LDL-C/HDL-C and TG/HDL-C were significantly higher and over the limit when assessing for atherogenic dyslipidemia. The number of patients at risk for cardiovascular events increases 2.5 folds in obese compared to non-obese. Measurement of waist circumference could be adopted as a simpler valid alternative to BMI for health promotion, to alert those at risk of atherogenic dyslipidemia.
Topics

No keywords indexed for this article. Browse by subject →

References
51
[1]
WHO (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, WHO. Available online: https://www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/.
[2]
OECD (2019). The Heavy Burden of Obesity: The Economics of Prevention, OECD Publishing. OECD Health Policy Studies. 10.1787/e3b23f8e-en
[3]
WHO (2020, November 01). The Top 10 Causes of Death 2018. Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
[4]
Tune "Cardiovascular consequences of metabolic syndrome" Transl. Res. (2017) 10.1016/j.trsl.2017.01.001
[5]
Youmans "Disparities in cardiovascular care: Past, present, and solutions" Clevel. Clin. J. Med. (2019) 10.3949/ccjm.86a.18088
[6]
Daviglus "Body mass index in middle age and health-related quality of life in older age: The Chicago heart association detection project in industry study" Arch. Intern. Med. (2003) 10.1001/archinte.163.20.2448
[7]
Hernández-Reyes, A., Cámara-Martos, F., Molina-Luque, R., Romero-Saldaña, M., Molina-Recio, G., and Moreno-Rojas, R. (2019). Changes in body composition with a hypocaloric diet combined with sedentary, moderate and high-intense physical activity: A randomized controlled trial. BMC Womens Health, 19. 10.1186/s12905-019-0864-5
[8]
Ghachem "Should Waist Circumference Cutoffs in the Context of Cardiometabolic Risk Factor Assessment be Specific to Sex, Age, and BMI?" Metab. Syndr. Relat. Disord. (2018) 10.1089/met.2017.0177
[9]
Ross "Waist circumference as a vital sign in clinical practice: A Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity" Nat. Rev. Endocrinol. (2020) 10.1038/s41574-019-0310-7
[10]
Song "Comparison of various surrogate obesity indicators as predictors of cardiovascular mortality in four European populations" Eur. J. Clin. Nutr. (2013) 10.1038/ejcn.2013.203
[11]
Nam "Obesity Fact Sheet in Korea, 2018: Data Focusing on Waist Circumference and Obesity-Related Comorbidities" J. Obes. Metab. Syndr. (2019) 10.7570/jomes.2019.28.4.236
[12]
Shen "Waist circumference correlates with metabolic syndrome indicators better than percentage fat" Obesity (Silver Spring) (2006) 10.1038/oby.2006.83
[13]
Zhang "A Study on the Factors Influencing Triglyceride Levels among Adults in Northeast China" Sci. Rep. (2018) 10.1038/s41598-018-24230-4
[14]
Arner "Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels" Arter. Thromb. Vasc. Biol. (2017) 10.1161/atvbaha.117.309759
[15]
Pouliot "Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women" Am. J. Cardiol. (1994) 10.1016/0002-9149(94)90676-9
[16]
Carr "Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome" Diabetes (2004) 10.2337/diabetes.53.8.2087
[17]
Meigs "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease" J. Clin. Endocrinol. Metab. (2006) 10.1210/jc.2006-0594
[18]
Ardern "Development of health-related waist circumference thresholds within BMI categories" Obes. Res. (2004) 10.1038/oby.2004.137
[19]
Ballantyne "Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S" Circulation (2001) 10.1161/hc5001.100624
[20]
Vega "Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men" J. Investig. Med. (2014) 10.2310/jim.0000000000000044
[21]
Ascaso "Management of dyslipidemia in the metabolic syndrome: Recommendations of the Spanish HDL-Forum" Am. J. Cardiovasc. Drugs (2007) 10.2165/00129784-200707010-00004
[22]
(2016, December 20). Encuesta Nacional de Salud 2011/2012. Ministerio de Sanidad, Servicios Sociales e Igualdad. Available online: http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/encuesta2011.htm.
[23]
Gidding "Cholesterol and Atherosclerotic Cardiovascular Disease: A Lifelong Problem" J. Am. Heart Assoc. (2019) 10.1161/jaha.119.012924
[24]
Robinson "Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life" J. Am. Heart Assoc. (2018) 10.1161/jaha.118.009778
[25]
Robinson "Determining When to Add Nonstatin Therapy: A Quantitative Approach" J. Am. Coll. Cardiol. (2016) 10.1016/j.jacc.2016.09.928
[26]
American Heart Association (2020, January 10). Cardiovascular Disease: A Costly Burden for America. Cost Projections through 2035. Available online: http://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_491543.pdf.
[27]
Ascaso "Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis" Clin. Investig. Arterioscler. (2017)
[28]
Tomlinson, D.J., Erskine, R.M., Morse, C.I., and Onambélé, G.L. (2019). Body Fat Percentage, Body Mass Index, Fat Mass Index and the Ageing Bone: Their Singular and Combined Roles Linked to Physical Activity and Diet. Nutrients, 11. 10.3390/nu11010195
[29]
Schubert "Reliability and validity of various laboratory methods of body composition assessment in young adults" Clin. Physiol. Funct. Imaging (2019) 10.1111/cpf.12550
[30]
Lean "Waist circumference as a measure for indicating need for weight management" BMJ (1995) 10.1136/bmj.311.6998.158
[31]
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

William T Friedewald, Robert I Levy, Donald S Fredrickson

Clinical Chemistry 1972 10.1093/clinchem/18.6.499
[32]
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al.

International Journal of Surgery 2014 10.1016/j.ijsu.2014.07.013
[33]
Vesa, C.M., Popa, L., Popa, A.R., Rus, M., Zaha, A.A., Bungau, S., Tit, D.M., Corb Aron, R.A., and Zaha, D.C. (2020). Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors. Diagnostics, 10. 10.3390/diagnostics10050314
[34]
Gheorghe, G., Toth, P.P., Bungau, S., Behl, T., Ilie, M., Pantea Stoian, A., Bratu, O.G., Bacalbasa, N., Rus, M., and Diaconu, C.C. (2020). Cardiovascular Risk and Statin Therapy Considerations in Women. Diagnostics, 10. 10.3390/diagnostics10070483
[35]
Song "Obesity attenuates gender differences in cardiovascular mortality" Cardiovasc. Diabetol. (2014) 10.1186/s12933-014-0144-5
[36]
Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., Burns, R., Rayner, M., and Townsend, N. (2017). European Cardiovascular Disease Statistics, Eur Hear Network. Available online: http://www.ehnheart.org/images/CVD-statistics-report-August-2017.pdf.
[37]
Khan "Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity" JAMA Cardiol. (2018) 10.1001/jamacardio.2018.0022
[38]
Clark "Cholesterol and heart disease: Current concepts in pathogenesis and treatment" J. Natl. Med. Assoc. (1986)
[39]
Furtado, J.M., Almeida, S.M., Mascarenhas, P., Ferraz, M.E., Ferreira, J.C., Vilanova, M., Monteiro, M.P., and Ferraz, F.P. (2018). Anthropometric features as predictors of atherogenic dyslipidemia and cardiovascular risk in a large population of school-aged children. PLoS ONE, 13. 10.1371/journal.pone.0197922
[40]
Holvoet "The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: The Multi-Ethnic Study of Atherosclerosis (MESA)" Atherosclerosis (2007) 10.1016/j.atherosclerosis.2006.08.002
[41]
Kwon "Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults" Medicine (Baltimore) (2019) 10.1097/md.0000000000017013
[42]
Stamler "Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity" JAMA (2000) 10.1001/jama.284.3.311
[43]
Klag "Serum cholesterol in young men and subsequent cardiovascular disease" N. Engl. J. Med. (1993) 10.1056/nejm199302043280504
[44]
Jeong "Effect of Change in Total Cholesterol Levels on Cardiovascular Disease Among Young Adults" J. Am. Heart Assoc. (2018) 10.1161/jaha.118.008819
[45]
Vinik "The metabolic basis of atherogenic dyslipidemia" Clin. Cornerstone (2005) 10.1016/s1098-3597(05)80065-1
[46]
Osadnik "Metabolically healthy obese and metabolic syndrome of the lean: The importance of diet quality. Analysis of MAGNETIC cohort" Nutr. J. (2020) 10.1186/s12937-020-00532-0
[47]
"Consumo de hipolipemiantes en España, 1987-2000" Rev. Esp. Salud. Publica (2001)
[48]
"La prevención secundaria de la enfermedad cardiovascular es prioritaria pero resulta insuficiente" Rev. Esp. Salud. Publica (1999)
[49]
Perk "European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)" Eur. Hearth J. (2012) 10.1093/eurheartj/ehs092
[50]
Kazi "Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease" JAMA (2016) 10.1001/jama.2016.11004

Showing 50 of 51 references

Metrics
13
Citations
51
References
Details
Published
Dec 02, 2020
Vol/Issue
10(12)
Pages
1033
License
View
Cite This Article
Alberto Hernández-Reyes, Angela Vidal, Alicia Moreno-Ortega, et al. (2020). Waist Circumference as a Preventive Tool of Atherogenic Dyslipidemia and Obesity-Associated Cardiovascular Risk in Young Adults Males: A Cross-Sectional Pilot Study. Diagnostics, 10(12), 1033. https://doi.org/10.3390/diagnostics10121033